<?xml version="1.0" encoding="UTF-8" ?>
<rdf:RDF xmlns:admin="http://webns.net/mvcb/" xmlns="http://purl.org/rss/1.0/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:prism="http://purl.org/rss/1.0/modules/prism/" xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:syn="http://purl.org/rss/1.0/modules/syndication/">
<channel rdf:about="https://biorxiv.org">
<admin:errorReportsTo rdf:resource="mailto:biorxiv@cshlpress.edu"/>
<title>bioRxiv Subject Collection: Genomics Bioinformatics</title>
<link>https://biorxiv.org</link>
<description>
This feed contains articles for bioRxiv Subject Collection "Genomics Bioinformatics"
</description>

<items>
<rdf:Seq>
<rdf:li rdf:resource="https://www.biorxiv.org/content/10.64898/2026.11.11.765857v1?rss=1"/>
<rdf:li rdf:resource="https://www.biorxiv.org/content/10.64898/2026.11.11.765824v1?rss=1"/>
<rdf:li rdf:resource="https://www.biorxiv.org/content/10.64898/2026.11.16.767003v1?rss=1"/>
<rdf:li rdf:resource="https://www.biorxiv.org/content/10.64898/2026.11.16.763092v1?rss=1"/>
<rdf:li rdf:resource="https://www.biorxiv.org/content/10.64898/2026.11.16.767041v1?rss=1"/>
<rdf:li rdf:resource="https://www.biorxiv.org/content/10.64898/2026.11.13.766116v1?rss=1"/>
<rdf:li rdf:resource="https://www.biorxiv.org/content/10.64898/2026.11.16.767022v1?rss=1"/>
<rdf:li rdf:resource="https://www.biorxiv.org/content/10.64898/2026.11.16.767070v1?rss=1"/>
<rdf:li rdf:resource="https://www.biorxiv.org/content/10.64898/2026.11.16.765329v1?rss=1"/>
<rdf:li rdf:resource="https://www.biorxiv.org/content/10.64898/2026.11.16.766985v1?rss=1"/>
<rdf:li rdf:resource="https://www.biorxiv.org/content/10.64898/2026.11.16.766934v1?rss=1"/>
<rdf:li rdf:resource="https://www.biorxiv.org/content/10.64898/2026.11.16.766993v1?rss=1"/>
<rdf:li rdf:resource="https://www.biorxiv.org/content/10.64898/2026.11.16.766951v1?rss=1"/>
<rdf:li rdf:resource="https://www.biorxiv.org/content/10.64898/2026.11.16.766965v1?rss=1"/>
<rdf:li rdf:resource="https://www.biorxiv.org/content/10.64898/2026.11.16.767028v1?rss=1"/>
<rdf:li rdf:resource="https://www.biorxiv.org/content/10.64898/2026.11.16.767046v1?rss=1"/>
<rdf:li rdf:resource="https://www.biorxiv.org/content/10.64898/2026.11.16.766986v1?rss=1"/>
<rdf:li rdf:resource="https://www.biorxiv.org/content/10.64898/2026.11.16.767064v1?rss=1"/>
<rdf:li rdf:resource="https://www.biorxiv.org/content/10.64898/2026.11.16.766929v1?rss=1"/>
<rdf:li rdf:resource="https://www.biorxiv.org/content/10.64898/2026.11.15.766879v1?rss=1"/>
<rdf:li rdf:resource="https://www.biorxiv.org/content/10.64898/2026.11.15.766871v1?rss=1"/>
<rdf:li rdf:resource="https://www.biorxiv.org/content/10.64898/2026.11.16.765117v1?rss=1"/>
<rdf:li rdf:resource="https://www.biorxiv.org/content/10.64898/2026.11.12.766082v1?rss=1"/>
<rdf:li rdf:resource="https://www.biorxiv.org/content/10.64898/2026.11.16.766906v1?rss=1"/>
<rdf:li rdf:resource="https://www.biorxiv.org/content/10.64898/2026.11.16.766980v1?rss=1"/>
<rdf:li rdf:resource="https://www.biorxiv.org/content/10.64898/2026.11.15.766341v1?rss=1"/>
<rdf:li rdf:resource="https://www.biorxiv.org/content/10.64898/2026.11.15.766634v1?rss=1"/>
<rdf:li rdf:resource="https://www.biorxiv.org/content/10.64898/2026.11.15.766670v1?rss=1"/>
<rdf:li rdf:resource="https://www.biorxiv.org/content/10.64898/2026.11.15.766769v1?rss=1"/>
<rdf:li rdf:resource="https://www.biorxiv.org/content/10.64898/2026.11.13.766598v1?rss=1"/>
</rdf:Seq>
</items>
<prism:eIssn/>
<prism:publicationName>bioRxiv</prism:publicationName>
<prism:issn/>

<image rdf:resource=""/>
</channel>
<image rdf:about="">
<title>bioRxiv</title>
<url>https://www.biorxiv.org/sites/default/files/bioRxiv_article.jpg</url>
<link>https://www.biorxiv.org</link>
</image>
<item rdf:about="https://www.biorxiv.org/content/10.64898/2026.11.11.765857v1?rss=1">
<title>
<![CDATA[
AlphaGenome 2 predicts regulatory activity and variant effects across cell states 
]]>
</title>
<link>
https://www.biorxiv.org/content/10.64898/2026.11.11.765857v1?rss=1
</link>
<description><![CDATA[
Most genetic variants associated with human traits and diseases lie in non-coding DNA, where they can alter gene regulation in specific cell types and states. Single-cell atlases chart these states across tissues and development, but rarely profile enough donors to associate variants with expression directly. Deep learning models could bridge this gap by predicting variant effects from DNA sequence, yet they poorly distinguish related cell states and require fine-tuning for new datasets. Here we present AlphaGenome 2 (AG2), which substantially advances cell-type-specific prediction of regulatory activity and variant effects for gene expression and chromatin accessibility. Trained on organism-wide human and mouse single-cell atlases and bulk functional genomics data, AG2 takes as input a 1-Mb DNA sequence and a condition specifying a target tissue, cell type, or cell state. Conditioning enables AG2 to impute unmeasured epigenomic tracks and predict multimodal variant effects across cell types. Inferring this condition directly from gene expression extends AG2 to unseen datasets and cell states without fine-tuning. AG2 outperforms fine-tuned AlphaGenome 1 and specialized models trained on target datasets, doubling recall of causal single-cell eQTLs at 90% precision. AG2 also achieves state-of-the-art enhancer-gene linking and can pinpoint causal variants at complex trait loci. Across hundreds of human cell types, we generated an atlas of enhancer-gene links and scores for 7 million common variants. As single-cell profiling expands across development, tissues, and disease cohorts, AG2 provides a blueprint for turning observational atlases into variant effect maps.
]]></description>
<dc:creator><![CDATA[ Gayoso, A., Mottram, A., Karollus, A., Novati, G., Drotar, P., Reid, J., Meng-Papaxanthos, L., Kosiorek, A., Arvaniti, E., Dutordoir, V., De, S., Ward, T., Hong Wong, L., Perino, M., Taylor, K., Cheng, J., Latysheva, N., Pan, J., Hariharan, D., Bycroft, C., Nicolaisen, L., Hassabis, D., Kohli, P., Avsec, Z. ]]></dc:creator>
<dc:date>2026-11-17</dc:date>
<dc:identifier>doi:10.64898/2026.11.11.765857</dc:identifier>
<dc:title><![CDATA[AlphaGenome 2 predicts regulatory activity and variant effects across cell states]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-11-17</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.biorxiv.org/content/10.64898/2026.11.11.765824v1?rss=1">
<title>
<![CDATA[
Evaluating local assembly strategies for human long-read structural variant calling 
]]>
</title>
<link>
https://www.biorxiv.org/content/10.64898/2026.11.11.765824v1?rss=1
</link>
<description><![CDATA[
Long-read sequencing enables detection of structural variants (SVs) with far greater accuracy and completeness than was previously possible. This advance has spurred the development of many SV callers that implement diverse algorithmic strategies. Commonly, SV calling proceeds in several processing steps. Evaluations of SV callers, however, typically focus on overall performance and conceal which steps drive observed differences. This hinders targeted, evidence-based improvements to existing SV calling approaches. Here, we implemented five consensus computation strategies similar to those employed by popular SV callers that perform a local assembly. We compare their outputs on extensive simulated and real data and reveal that some strategies are more effective for particular input data types. For example, the strategy employed by PacBio's tool Sawfish works very well on HiFi reads and recent ONT data, but fails on the older and noisier ONT reads. While the read error profiles and the read pre-processing has a substantial influence on some strategies, other strategies are more robust overall. These findings guide algorithmic decisions for the development of improved future SV callers.
]]></description>
<dc:creator><![CDATA[ Mirus, T., Luepken, R., Kehr, B. ]]></dc:creator>
<dc:date>2026-11-17</dc:date>
<dc:identifier>doi:10.64898/2026.11.11.765824</dc:identifier>
<dc:title><![CDATA[Evaluating local assembly strategies for human long-read structural variant calling]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-11-17</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.biorxiv.org/content/10.64898/2026.11.16.767003v1?rss=1">
<title>
<![CDATA[
statLens enables accurate and interpretable statistical intelligence 
]]>
</title>
<link>
https://www.biorxiv.org/content/10.64898/2026.11.16.767003v1?rss=1
</link>
<description><![CDATA[
Diverse existing approaches and analyses of large-scale biomedical omics datasets along with the complexity of the corresponding statistical analytical workflows pose challenges to the direct application of large language models (LLMs) to data analysis tasks. We present statLens, a model-agnostic AI-driven statistical intelligence framework that integrates LLMs, code and human review. We demonstrate statLens using differential expression analysis across heterogeneous biomedical data as a use case. On 102 benchmark tasks from 74 datasets across six omics modalities, statLens maintained consistently high accuracy (92.5--95.0%) across seven language models and outperformed LLM-only inference (17.5--46.8%), whereas autonomous-agent accuracy varied widely (58.7--99.5%). We also showed that statLens substantially improved the accuracy of the four small language models (92.5--94.4%) over autonomous agents (58.7--92.2%) and LLM-only inference (17.5--43.5%). By decomposing analytical workflows into complementary tasks for code, LLMs and human experts, statLens provides an integrated framework for more accurate, interpretable and reproducible AI-assisted data analysis, particularly in complex omics settings.
]]></description>
<dc:creator><![CDATA[ Fu, D., Patil, A., Kush, U., Taheriyoun, A. R., Rahnavard, A. ]]></dc:creator>
<dc:date>2026-11-17</dc:date>
<dc:identifier>doi:10.64898/2026.11.16.767003</dc:identifier>
<dc:title><![CDATA[statLens enables accurate and interpretable statistical intelligence]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-11-17</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.biorxiv.org/content/10.64898/2026.11.16.763092v1?rss=1">
<title>
<![CDATA[
SpaceMACE: Spatially-Aware Tumour Cell Annotation for Spatial Transcriptomics 
]]>
</title>
<link>
https://www.biorxiv.org/content/10.64898/2026.11.16.763092v1?rss=1
</link>
<description><![CDATA[
Accurate discrimination between tumour and non-tumour cells is essential for interpreting spatial transcriptomics data and identifying spatially resolved therapeutic targets. Existing tumour-cell annotation approaches were primarily developed for single-cell RNA sequencing and do not explicitly incorporate the spatial organization of cells. Here, we introduce SpaceMACE, an extension of the MACE tumour-cell annotation framework for sequencing-based and imaging-based spatial transcriptomics. SpaceMACE first combines reference-based cell-type classification with copy-number-variation-based tumour classification. The resulting consensus annotations are subsequently refined using spatial proximity and gene-expression similarity. We evaluated SpaceMACE across multiple spatial transcriptomics platforms, including Stereo-seq, Visium HD, CosMx and Xenium, and across colorectal, hepatocellular and ovarian cancer datasets. SpaceMACE retained the high precision of the original MACE framework while improving the spatial coherence of tumour-cell annotations. Together, these results demonstrate that SpaceMACE provides a scalable and platform-independent framework for tumour-cell annotation in spatial transcriptomics and supports the spatial investigation of tumour-specific molecular targets.
]]></description>
<dc:creator><![CDATA[ D'Agostini, D., Abdelaal, T. ]]></dc:creator>
<dc:date>2026-11-17</dc:date>
<dc:identifier>doi:10.64898/2026.11.16.763092</dc:identifier>
<dc:title><![CDATA[SpaceMACE: Spatially-Aware Tumour Cell Annotation for Spatial Transcriptomics]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-11-17</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.biorxiv.org/content/10.64898/2026.11.16.767041v1?rss=1">
<title>
<![CDATA[
Cell-state conditioning predicts the expression response to an unseen stimulus but not stimulus-dependent genetic effects 
]]>
</title>
<link>
https://www.biorxiv.org/content/10.64898/2026.11.16.767041v1?rss=1
</link>
<description><![CDATA[
Second-generation sequence models can be conditioned on a cell state supplied as a single-cell snapshot rather than selected from a fixed catalogue, but whether that conditioning carries an experimentally applied perturbation has not been tested. We conditioned such a model on interferon-{beta}-stimulated and unstimulated monocytes from a published experiment, using cells disjoint from those providing the measurement, and asked whether the predicted expression response tracks the measured one and whether the same conditioning identifies expression QTL specific to the stimulated state. Predicted and measured responses agree at Spearman {rho} = 0.616 across 119 genes (95% CI 0.486 to 0.716), and at 0.607 after all 119 target genes are deleted from the conditioning input; across fifteen conditions the model's response scales with how much each condition's biology genuinely overlaps the target response (slope 0.73, Pearson 0.92), and a near-neighbour monocyte subset receives 0.295 against a measured overlap of 0.336. For stimulation-specific genetic effects we find no reliable evidence: the pre-specified primary arm moves from p = 0.0019 to 0.443 once both conditions must carry a measurable predicted effect, and the separation localises to the resting-condition baseline. Neither model generation's catalogue contains a perturbed sample, 0 of 4,430 tracks and 0 of 2,799 conditions, although both carry activation-state labels, so the gap is experimental perturbation rather than cell state. Two incidental findings apply beyond this model: credible-set membership mislabels over half of putatively condition-specific loci, and gating a ratio statistic on its larger term manufactures signal.
]]></description>
<dc:creator><![CDATA[ He, H., Sun, J., Xu, J., Abudureyimu, M., Yang, Y., Huang, Y., Wang, Z., Xia, Q., Wang, S. ]]></dc:creator>
<dc:date>2026-11-17</dc:date>
<dc:identifier>doi:10.64898/2026.11.16.767041</dc:identifier>
<dc:title><![CDATA[Cell-state conditioning predicts the expression response to an unseen stimulus but not stimulus-dependent genetic effects]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-11-17</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.biorxiv.org/content/10.64898/2026.11.13.766116v1?rss=1">
<title>
<![CDATA[
Measuring Phylogenetic Information Content Based on Clade Support 
]]>
</title>
<link>
https://www.biorxiv.org/content/10.64898/2026.11.13.766116v1?rss=1
</link>
<description><![CDATA[
Phylogenetic information content is often understood as the degree to which data lend support to hypotheses about the monophyly of clades. This is most commonly expressed in terms of clade support, typically estimated by resampling techniques such as the bootstrap and the jackknife. Here, I discuss how to summarize this aspect of data quality. I show that raw bootstrap or jackknife proportions are unsuitable for this purpose and instead suggest a logarithmic transformation, which can be interpreted as translating the clade support values to the number of characters expected to give the same resampling proportion in parsimony analysis of a homoplasy-free data matrix. The distribution of the number of these "supporting characters" and descriptive statistics derived from this distribution, such as the mean (Mean Character Support, or MCS) and its standard deviation, provide powerful summaries of the quality of the underlying data set. I demonstrate for both empirical and simulated data sets that MCS accurately reflects information content, and that some popular alternative measures of data quality (the ensemble consistency index, the ensemble retention index, data decisiveness and the total support index) do not. Unlike most other measures of data quality, MCS can be applied to trees resulting from a range of alternative phylogenetic methods, including parsimony, distance and maximum likelihood approaches.
]]></description>
<dc:creator><![CDATA[ Nylander, J. A. A. ]]></dc:creator>
<dc:date>2026-11-17</dc:date>
<dc:identifier>doi:10.64898/2026.11.13.766116</dc:identifier>
<dc:title><![CDATA[Measuring Phylogenetic Information Content Based on Clade Support]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-11-17</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.biorxiv.org/content/10.64898/2026.11.16.767022v1?rss=1">
<title>
<![CDATA[
Policy-Enforced Genomic Repositories and Institutional Data Governance for African Pathogen Surveillance with UbuntuBio 
]]>
</title>
<link>
https://www.biorxiv.org/content/10.64898/2026.11.16.767022v1?rss=1
</link>
<description><![CDATA[
Research centers curating pathogen sequence cohorts often operate under constrained bandwidth, multi-institutional data-sharing agreements, and strict biosafety requirements. Global public archives keep released sequences permanently open, external viral portals enforce terms outside local institutional custody, and standard Git Large File Storage (LFS) duplicates identical binaries across repositories without validating taxonomy or geography. We present UbuntuBio (v1.0.0), a Git-native, policy-enforced genomic repository platform deployed at https://ubuntubio.org and developed at the West African Centre for Cell Biology of Infectious Pathogens (WACCBIP), University of Ghana. UbuntuBio integrates four mechanisms under a single storage root: (1) bare Git repositories storing dataset cards, sample sheets, and approximately 130-byte LFS pointers backed by prefix-sharded SHA-256 content-addressed storage (CAS) with visibility-scoped wire deduplication; (2) a four-phase commit pipeline recoverable via cross-plane reconciliation that enforces 55 African Union country codes against offline Natural Earth polygons, core MIxS-derived fields, Taxon 9606 rejection, and server-keyed targeted human-marker screening identically across HTTP commits and Git pre-receive hooks; (3) institutional custody controls combining Data Use Agreements (DUAs), revocable 900-second RS256 capability tokens, key rotation, tamper-evident hash-chained logs, and externally anchorable RS256 audit checkpoints; and (4) an embedded SQLite WAL and FTS5 catalog filtered by access tier. In single-node evaluation, UbuntuBio classified 18/18 policy boundary fixtures consistently across Python, Git, and HTTP paths; showed 0/265,157 false cross-matches on 21/22 RefSeq pathogen sequences (while cross-matching Candida albicans 18S rDNA at 0.113% and Chlorocebus sabaeus Alu repeats in ENA stool reads, confirming targeted marker detection rather than verified human DNA decontamination); matched conditional uniform (n = 2,000; 200-seed 0.01% convergence 19.0% vs. 18.13% expected) and interior (n = 1,000) detection theory while detecting all spike-ins at [&ge;] 0.5% (30/30); halved two-repository disk usage on 613.83 MiB Nigerian E. coli runs; passed 27/27 structured-filter correctness checks over 10,000 biosamples and reached graded NDCG@10 = 0.920 on independent free-text BM25 queries with zero private leaks; and recovered cleanly across seven injected phase-transition faults.
]]></description>
<dc:creator><![CDATA[ Tetteh, A. S., Salami, R. O., Ansah, R. O., Buabeng, K. B., Agyenkwa-Mawuli, K., Baah, D., Sarpong, K., Rathod, A., Hodgson, J. N. O., Akorful, R. A. A., Miah, B. D.-g., Ayimadu, A. A., Amoako, E. K., Kumordzi, S. M., Abakah, A., Tawiah-Yingar, N. Y., Akakpo, D., Adade, R., Okekale, E. S., Senyo, M. T. ]]></dc:creator>
<dc:date>2026-11-17</dc:date>
<dc:identifier>doi:10.64898/2026.11.16.767022</dc:identifier>
<dc:title><![CDATA[Policy-Enforced Genomic Repositories and Institutional Data Governance for African Pathogen Surveillance with UbuntuBio]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-11-17</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.biorxiv.org/content/10.64898/2026.11.16.767070v1?rss=1">
<title>
<![CDATA[
KORUS: probabilistic ancestry inference beyond variant calls 
]]>
</title>
<link>
https://www.biorxiv.org/content/10.64898/2026.11.16.767070v1?rss=1
</link>
<description><![CDATA[
Ancestry inference typically relies on variant calling and predefined population labels. We present KORUS, a probabilistic framework that infers ancestry from sequencing-derived k-mer representations constructed using ancestry-informative reference variants and encoded in Bloom filters, without requiring explicit variant calls for query genomes. KORUS separates genomic feature representation from ancestry decoding, enabling supervised classification, fractional ancestry inference, and unsupervised population structure discovery within a unified framework. Reference models were constructed from 643 genomes from the 1000 Genomes Project and the Simons Genome Diversity Project. Evaluation on an independent cohort of 22 whole-genome sequencing samples, with comparisons to ntRoot, SNVstory, and ADMIXTURE, showed recovery of continental-scale population structure, with supervised classification accuracy of 72.7-81.8% and ancestry-fraction concordance of R2 = 0.844-0.993 relative to ADMIXTURE and R2 = 0.665-0.983 relative to ntRoot. Ancestry estimates were consistent across alternative k-mer representations. Analyses of ancient human and archaic hominin genomes demonstrated that probabilistic projections quantify affinity to the learned feature space rather than necessarily indicating modern continental ancestry. KORUS provides a unified approach to ancestry inference directly from sequencing-derived representations and is freely available under the GPLv3 license at https://github.com/BirolLab/korus.
]]></description>
<dc:creator><![CDATA[ Warren, R. L., Coombe, L., Birol, I. ]]></dc:creator>
<dc:date>2026-11-17</dc:date>
<dc:identifier>doi:10.64898/2026.11.16.767070</dc:identifier>
<dc:title><![CDATA[KORUS: probabilistic ancestry inference beyond variant calls]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-11-17</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.biorxiv.org/content/10.64898/2026.11.16.765329v1?rss=1">
<title>
<![CDATA[
The pangenome of the Arctic picoeukaryote Micromonas polaris resolves cryptic ecotypes and identifies a polar-specific gene repertoire 
]]>
</title>
<link>
https://www.biorxiv.org/content/10.64898/2026.11.16.765329v1?rss=1
</link>
<description><![CDATA[
Micromonas polaris is the dominant picoeukaryote of the Arctic Ocean, where it sustains primary production across habitats from sea ice to open water to the subsurface chlorophyll maximum. How a single species maintains this ecological breadth has remained unclear. Standard phylogenetic markers such as 18S rRNA are nearly invariant within M. polaris and conceal any internal genomic heterogeneity the species may possess. Here we present a pangenome of 14 M. polaris strains spanning the Arctic basin, integrated with Tara Oceans metagenomes, that resolves the species into two diverged ecotypes invisible to 18S rRNA but recovered consistently by prp8, genome-wide SNPs, ANI, and orthogroup-based phylogenies. The two ecotypes coexist sympatrically, with one lineage consistently enriched deeper in the water column across the basin. M. polaris carries 990 polar-specific hierarchical orthogroups absent from temperate Micromonas, organised around one-carbon metabolism, endocytosis, transmembrane transport, and photo-oxidative stress response. Several components show phylogenetic signatures of horizontal acquisition from co-occurring marine taxa. Atlantification is bringing temperate Micromonas into Arctic margins seasonally, but the polar night likely limits their year-round persistence. M. polaris and its polar-specific toolkit appear positioned to persist through the dark season, suggesting Arctic margins will undergo seasonal turnover rather than stable replacement.
]]></description>
<dc:creator><![CDATA[ Jackson, V. L. N., Harrison, K., Derelle, E., Chambouvet, A., Lovejoy, C., Monier, A. ]]></dc:creator>
<dc:date>2026-11-17</dc:date>
<dc:identifier>doi:10.64898/2026.11.16.765329</dc:identifier>
<dc:title><![CDATA[The pangenome of the Arctic picoeukaryote Micromonas polaris resolves cryptic ecotypes and identifies a polar-specific gene repertoire]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-11-17</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.biorxiv.org/content/10.64898/2026.11.16.766985v1?rss=1">
<title>
<![CDATA[
Vertical transmission and community turnover in seed-borne microbiomes: lessons from an aMAIZEing model system 
]]>
</title>
<link>
https://www.biorxiv.org/content/10.64898/2026.11.16.766985v1?rss=1
</link>
<description><![CDATA[
The seed microbiome represents a specialized ecological niche, governed by assembly processes that are only partially coupled to the surrounding soil community. While environmental recruitment and vertical transmission from the maternal plant are both recognized sources of seed-associated microorganisms, the mechanisms that determine their relative contributions and whether these contributions shift across generations remain poorly understood. Here, we used long-read metagenomic sequencing to track seed-borne bacterial community dynamics across a founding seed pool and two subsequent generations in two divergent maize (Zea mays L.) varieties exposed to contrasting organic and mineral fertilisation regimes. We recovered 112 medium- or high-quality metagenome-assembled genomes and combined MAG-level taxonomic and functional analyses with genus-level community profiling to characterize persistence and turnover dynamics within the seed microbiome. While soil taxonomic diversity was high, seed-associated communities showed a near-complete compositional disconnect from soil-dominant assemblages taxa, with a persistent Firmicutes core maintained across generations, consistent with vertical transmission. Priority effects remain a possible explanation for these patterns but were not directly tested. Genus-level source attribution suggested greater environmental recruitment under organic fertilization, with more diverse soil communities and a stronger contribution from the preceding seed generation under mineral fertilization. Seed-associated MAGs also carried genes associated with plant growth-promoting potential, although these detections could not be consistently linked to specific transmission routes. In contrast, maize genotype had no detectable effect on seed microbiome composition. Intergenerational persistence and environmental recruitment jointly shape seed-derived communities under contrasting fertilization regimes. Their relative contributions remain inferred from taxonomic overlap, and the effects of microbial source-pool diversity cannot be separated from the accompanying differences in soil chemistry in this design.
]]></description>
<dc:creator><![CDATA[ Henaut Jacobs, S., Sangi, S., Matos, J. P., Chaves Ribeiro, R., Petroceli-Mota, G., da Costa Rodrigues, B., Jario de Lima, V., Kamphorst, S. H., Alves de Oliveira, U., Nunes-da-Fonseca, R., Lopes Olivares, F., S. Etienne, R., M. Venancio, T. ]]></dc:creator>
<dc:date>2026-11-17</dc:date>
<dc:identifier>doi:10.64898/2026.11.16.766985</dc:identifier>
<dc:title><![CDATA[Vertical transmission and community turnover in seed-borne microbiomes: lessons from an aMAIZEing model system]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-11-17</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.biorxiv.org/content/10.64898/2026.11.16.766934v1?rss=1">
<title>
<![CDATA[
Generative Data Augmentation for Small-Cohort Glioblastoma Diagnosis from Circulating microRNA: Why Same-Modality Validation Overstates Performance 
]]>
</title>
<link>
https://www.biorxiv.org/content/10.64898/2026.11.16.766934v1?rss=1
</link>
<description><![CDATA[
Circulating microRNAs (miRNAs) have potential as minimally invasive biomarkers for glioblastoma (GBM), but the small size of discovery groups makes it difficult to develop a classifier. The discovery cohort, GSE122488, comprised 38 patients (n = 38). Generative data augmentation was applied to increase the dataset, although evaluations based on held-out samples from the same cohort or a single validation set make it difficult to distinguish biological signals from cohort- or platform-specific effects. CTGAN and Tabular Variational Autoencoder (TVAE) models were trained on the 38-patient cohort producing 500 synthetic samples each. Random Forest and XGBoost classifiers were trained on augmented datasets and assessed using an escalating validation approach: first on an independent plasma cohort of the same modality (GSE184472, n = 118), and then on a tissue cohort from a different platform (Chinese Glioma Genome Atlas (CGGA), n = 198). XGBoost using TVAE-augmented data achieved an AUROC of 0.59 (95% CI 0.49-0.70) on GSE184472, compared with 0.42 to 0.53 without augmentation, although no AUROC on this cohort was significantly different from chance. However, this improvement did not carry to CGGA, where AUROC was 0.40 (95% CI 0.32-0.48) before harmonisation and 0.47 after Min-Max harmonisation. After harmonisation, a recall of 1.00 resulted from predicting every sample as GBM, leading to an accuracy of 0.41 and showing poor discrimination. The generalisation gap was examined in terms of modality mismatch, differing class definitions between cohorts, synthetic-data-related class imbalance, and incomplete cross-platform harmonisation. These findings show the need for independent, cross-platform validation before using data augmentation for diagnosis. The escalating validation framework provides a way to evaluate generalizability in small-cohort studies.
]]></description>
<dc:creator><![CDATA[ Rane, S., Mishra, S., Carvalho, P., Gurjar, V., Tiwari, R., Mishra, P. K. ]]></dc:creator>
<dc:date>2026-11-17</dc:date>
<dc:identifier>doi:10.64898/2026.11.16.766934</dc:identifier>
<dc:title><![CDATA[Generative Data Augmentation for Small-Cohort Glioblastoma Diagnosis from Circulating microRNA: Why Same-Modality Validation Overstates Performance]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-11-17</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.biorxiv.org/content/10.64898/2026.11.16.766993v1?rss=1">
<title>
<![CDATA[
Deciphering the Biological Function of Tandem Mass Spectra Using a Dual-Modal Metabolite Language Model 
]]>
</title>
<link>
https://www.biorxiv.org/content/10.64898/2026.11.16.766993v1?rss=1
</link>
<description><![CDATA[
Liquid chromatography-tandem mass spectrometry untargeted metabolomics captures thousands of metabolic peaks from biological samples. Conventional identification-dependent metabolomics workflows require confident structural annotation before identified features can enter downstream pathway or functional analysis. However, only a small fraction of detected metabolic features can be assigned confident structural annotations, leaving a large fraction difficult to incorporate into downstream biological interpretation, a form of "functional dark matter". Here, we introduce Spec2Function, a function-centric framework that infers biological functions from tandem mass spectrometry (MS2) spectra. Spec2Function is trained using characterized spectrum-text pairs but does not require prior structural identification of the query spectra at inference time. At its core is Spec2Biotext, a dual-encoder contrastive model that embeds MS2 spectra and curated multi-aspect natural language functional texts into a unified functional space. Combined with a retrieval-augmented generation framework grounded in curated databases and biomedical literature, Spec2Function retrieves evidence-grounded biological knowledge and produces coherent functional summaries for individual spectra or groups of spectra. Across metabolite- and pathway-level benchmarks, Spec2Function achieved higher similarity to reference functional descriptions than the evaluated comparators and expanded the fraction of the metabolome accessible to functional interpretation. Application to a human liver cirrhosis cohort recapitulated known metabolic alterations and identified additional literature-supported functional modules. Applying Spec2Function to a 30-organ macaque aging atlas revealed organ-specific metabolic functions and previously unreported functional modules that were supported by independent human and mouse datasets. Together, these results position Spec2Function as a function-centric framework for scalable biological interpretation of structurally unannotated MS2 spectra.
]]></description>
<dc:creator><![CDATA[ Zhang, F., Wang, Y., Liu, Y., Kinchagawat, J., Wang, C., Wang, W., Fu, Y., Kong, Q., Shen, X. ]]></dc:creator>
<dc:date>2026-11-17</dc:date>
<dc:identifier>doi:10.64898/2026.11.16.766993</dc:identifier>
<dc:title><![CDATA[Deciphering the Biological Function of Tandem Mass Spectra Using a Dual-Modal Metabolite Language Model]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-11-17</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.biorxiv.org/content/10.64898/2026.11.16.766951v1?rss=1">
<title>
<![CDATA[
Automated segmentation of renal structures using brightfield images of unstained kidney biopsies 
]]>
</title>
<link>
https://www.biorxiv.org/content/10.64898/2026.11.16.766951v1?rss=1
</link>
<description><![CDATA[
The automated segmentation of unstained kidney brightfield microscopy images remains a significant challenge in medical imaging. In conventional histopathology, staining provides crucial structural and molecular contrast, allowing renal compartments and structures to be readily distinguished. The absence of staining markedly reduces this contrast, obscuring the fine architectural details that are essential for diagnosis. Addressing this gap would reduce reliance on staining protocols, reduce technical and interpretive variability, and preserve valuable tissue for downstream molecular or multi-omics analyses. Ultimately, automation of unstained image segmentation could enable faster, more objective tissue analysis while preserving samples for further molecular testing. In this work, we provide a comprehensive review of state-of-the-art segmentation methods applied to renal brightfield microscopy images. Current findings highlight a predominance of Convolutional Neural Network (CNN) based architectures for semantic segmentation approaches while recent trends point to the growing application of transformer-based and instance-segmentation strategies. However, the field is still hampered by the scarcity and poor annotation of publicly available renal datasets. Aiming to further contribute to the enhancement of the field, a dataset of 18 Whole Slide Images (WSIs) of unstained human kidney tissue is made publicly available. Additionally, in the dataset, we provide 543 annotated tiles extracted from the WSIs, facilitating further research into stain-independent segmentation approaches. As a third contribution, we present a preliminary case study, evaluating state-of-the-art deep learning segmentation architectures, including U-Net and Segment Anything Model (SAM). Our preliminary results indicate that deep learning models demonstrate promising segmentation performance in unstained kidney biopsies. In alignment with these findings, advanced customised loss functions and data augmentation were integrated into the supervised training of the promising U-Net, DeepLabv3+, and TransUNet models, achieving significant improvements compared to the baseline experiments. To exploit the abundance of unlabelled data, we further tested FixMatchSeg, a semi-supervised learning method; however, its segmentation performance remained slightly behind the supervised methods. Taken together, these contributions establish a foundation for future research in stain-independent Computational Pathology, demonstrating that unstained brightfield microscopy images can reliably support downstream tissue analysis tasks. Our dataset, validation experiments, and methodological insights provide the community with both resources and benchmarks to advance robust, data-efficient, and generalisable kidney tissue segmentation.
]]></description>
<dc:creator><![CDATA[ Osiecka Carvalho, M., Brandao, I., Pestana e Silva, R. N., Oliveira, J. P., Soares Alencastre, I., Santos Cardoso, J. ]]></dc:creator>
<dc:date>2026-11-17</dc:date>
<dc:identifier>doi:10.64898/2026.11.16.766951</dc:identifier>
<dc:title><![CDATA[Automated segmentation of renal structures using brightfield images of unstained kidney biopsies]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-11-17</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.biorxiv.org/content/10.64898/2026.11.16.766965v1?rss=1">
<title>
<![CDATA[
QT-RelCor: Statistical Inference for Comorbidity of Quantitative Traits and Disease from Related Individuals 
]]>
</title>
<link>
https://www.biorxiv.org/content/10.64898/2026.11.16.766965v1?rss=1
</link>
<description><![CDATA[
Background: Complex diseases with a high genetic component often cluster in families and are associated with quantitative traits (QT-s) such as endophenotypes showing comorbidity with the end-point disease trait. Detecting associations with such QT-s can provide a non-invasive approach to indicate disease onset at an early stage, or help in tracking disease severity. Traditional case-control studies generally involve unrelated individuals, which can introduce heterogeneity due to varying lifestyle and exposure patterns. Often QT values may be available from related individuals such as families of affected probands. In these situations, assessment of comorbidity restricting to unrelated cases and controls leads to unnecessary loss of power. On the other hand, ignoring the correlation structure of families leads to grossly incorrect confidence intervals impacting both type 1 error and power of tests. Yet, these practices are common in the absence of standard inference procedures for such data. Methods: We propose statistical procedures for analyzing clustered data to infer association between the QT-s and the binary trait. The methods allow a mix of families and unrelated cases and utilizes all available individuals. In particular, two novel competing approaches are proposed and evaluated: a parametric approach based on multivariate normal likelihood and a non-parametric approach that combines the Wilcoxon rank-sum test with a modified version of the Wilcoxon signed-rank test. Results: We conducted simulation studies to assess type 1 error and power across multiple scenarios, which demonstrated the robustness of the proposed tests. Both the tests perform considerably better than both the classical t-test and Wilcoxon signed-rank test under both parametric and non-parametric settings. We illustrate the proposed methods by applying them on sibship data from the Centre for Brain and Mind program to identify a number of quantitative precursors significantly associated with schizophrenia and bipolar disorder. Conclusion: In summary, the proposed methods provide a robust and powerful approach to detect comorbid endophenotypes incorporating data from families of affected individuals. Findings from the analysis of sibling-based data on schizophrenia and bipolar disorder support role of a few selected neurocognitive assessments as potential markers of these disorders.
]]></description>
<dc:creator><![CDATA[ Panja, P., Jayasankar, P., Nayok, S. B., Viswanath, B., Purushottam, M., Jain, S., Bhattacharjee, S. ]]></dc:creator>
<dc:date>2026-11-17</dc:date>
<dc:identifier>doi:10.64898/2026.11.16.766965</dc:identifier>
<dc:title><![CDATA[QT-RelCor: Statistical Inference for Comorbidity of Quantitative Traits and Disease from Related Individuals]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-11-17</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.biorxiv.org/content/10.64898/2026.11.16.767028v1?rss=1">
<title>
<![CDATA[
Quantum Machine Learning for Missense Variant Pathogenicity Prediction in the KCNQ Gene Family 
]]>
</title>
<link>
https://www.biorxiv.org/content/10.64898/2026.11.16.767028v1?rss=1
</link>
<description><![CDATA[
Missense variants in the KCNQ family of voltage-gated potassium channel genes are associated with a broad spectrum of neurological and cardiac disorders for which computational tools capable of differentiating benign and pathogenic variants are essential. Here, we present, to our knowledge, the first application of quantum machine learning (QML) to missense pathogenicity prediction. We employ a hybrid quantum framework combining data re-uploading quantum neural networks with quantum support vector machines and applied it to pathogenicity classification across the full KCNQ gene family. Systematic exploration of circuit architectures revealed that optimal hyperparameter choices enable the proposed quantum model to achieve predictive performance superior to or comparable to state-of-the-art classical machine learning approaches, reaching AUC-ROC values of approximately 0.94 across the full dataset. Although no clear quantum advantage is observed at present, these results demonstrate that quantum feature representations can effectively capture biologically relevant patterns in variant data and establish QML as a viable framework for future applications in computational genomics and precision medicine.
]]></description>
<dc:creator><![CDATA[ G Ibarluzea, M., Capponi, S., Leonardo, A., Bergara, A. ]]></dc:creator>
<dc:date>2026-11-17</dc:date>
<dc:identifier>doi:10.64898/2026.11.16.767028</dc:identifier>
<dc:title><![CDATA[Quantum Machine Learning for Missense Variant Pathogenicity Prediction in the KCNQ Gene Family]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-11-17</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.biorxiv.org/content/10.64898/2026.11.16.767046v1?rss=1">
<title>
<![CDATA[
S-PLM-TM enables fast and accurate sequence-based search for remote homologs 
]]>
</title>
<link>
https://www.biorxiv.org/content/10.64898/2026.11.16.767046v1?rss=1
</link>
<description><![CDATA[
Protein structures and functions can remain conserved after extensive sequence divergence, but detecting these distant relationships across large databases remains challenging. Here we present S-PLM-TM, a sequence-only remote homology search tool based on a structure-aware protein language model. Cross-modal flow matching and contrastive learning incorporate structural information into sequence representations. A lightweight calibration head enables structural-similarity search with the frozen encoder, while a residue-level alignment head generates structural alignments directly from sequence. S-PLM-TM outperforms the tested sequence-based methods in remote homology detection, rivals structure-based methods in structural classification and retrieves the most functionally consistent neighbors. It also retrieves distantly related enzymes with shared catalytic functions at a level comparable to the best-performing structure-based methods. In large-scale database search, S-PLM-TM achieves the highest average precision among both sequence-based and alignment-free methods, with speed approaching the fastest sequence-alignment tools. Together, these results establish S-PLM-TM as a practical tool that combines sensitive and biologically informative remote homology search with the speed required for database-scale retrieval.
]]></description>
<dc:creator><![CDATA[ Wang, D., Zhang, Y., Zeng, S., Jiang, Y., Shao, Q., Xu, D. ]]></dc:creator>
<dc:date>2026-11-17</dc:date>
<dc:identifier>doi:10.64898/2026.11.16.767046</dc:identifier>
<dc:title><![CDATA[S-PLM-TM enables fast and accurate sequence-based search for remote homologs]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-11-17</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.biorxiv.org/content/10.64898/2026.11.16.766986v1?rss=1">
<title>
<![CDATA[
Genetic regulation of ALK inhibitor response in diverse human cell types 
]]>
</title>
<link>
https://www.biorxiv.org/content/10.64898/2026.11.16.766986v1?rss=1
</link>
<description><![CDATA[
Anaplastic lymphoma kinase (ALK) inhibitors are effective treatments for ALK-positive non-small cell lung cancer but cause diverse adverse events affecting multiple tissues. Genetic variation may contribute to inter-individual differences in susceptibility, but the small number of treated patients limits the power of genetic association studies. Moreover, the diversity of affected tissues and cell types makes functional investigation challenging. We used induced pluripotent stem cells from 49 individuals to generate heterogeneous differentiating cultures (HDCs) containing multiple cell types, treated them with five ALK inhibitors (crizotinib, alectinib, ceritinib, brigatinib, and lorlatinib) for 24 hours, and characterized transcriptional responses using single-cell RNA sequencing. These responses showed cell-type-specific and shared transcriptional effects. Integrating gene expression with individual genotypes, we identified 4,371 expression quantitative trait loci (eQTLs) across 21 cell types, including 2,137 response eQTLs whose regulatory effects differ between untreated and drug-treated cells. These results nominate candidates for future studies of ALK inhibitor toxicity.
]]></description>
<dc:creator><![CDATA[ Woo, E. G., Rhodes, K. L., Gonzales, N. M., Barr, K. A., Mohsin, E., Vokes, E. E., Gilad, Y. ]]></dc:creator>
<dc:date>2026-11-17</dc:date>
<dc:identifier>doi:10.64898/2026.11.16.766986</dc:identifier>
<dc:title><![CDATA[Genetic regulation of ALK inhibitor response in diverse human cell types]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-11-17</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.biorxiv.org/content/10.64898/2026.11.16.767064v1?rss=1">
<title>
<![CDATA[
Pharmacological and genetic access to astrocytic cholesterol programs in human neural cells 
]]>
</title>
<link>
https://www.biorxiv.org/content/10.64898/2026.11.16.767064v1?rss=1
</link>
<description><![CDATA[
Astrocyte-neuron interactions coordinate cholesterol metabolism, cell adhesion, and synaptic gene expression1,2, and related gene expression programs decline together in schizophrenia3. Whether pharmacological or genetic perturbations can selectively engage components of this coordinated biology was unknown. Here we combine genetically diverse cultures of human stem-cell-derived neurons and astrocytes, pharmacological profiling, genetic association mapping and CRISPR interference to examine these biological programs. In stem-cell-derived astrocyte mono-cultures, the antipsychotic clozapine induced a focused transcriptional response involving cholesterol biosynthesis and export, and drove an increase in intracellular and secreted cholesterol. This response overlapped with the cholesterol-related component of the astrocytic response to neuronal contact seen in neuron-astrocyte co-cultures, but did not extend to synaptic cell-adhesion genes. In neuron-astrocyte co-cultures, clozapine also increased neuronal firing. Across individual cell donors, cholesterol-pathway induction by clozapine was broadly shared but varied in magnitude. Gene-expression patterns in untreated donors were associated with differential responses to clozapine and the liver X receptor agonist GW3965. Common genetic variation influenced expression of several cholesterol-related genes, including a clozapine-dependent association of HSD17B7 expression with nearby genetic variants. Independently, repression of LDLR induced coordinated expression of cholesterol-biosynthesis genes in astrocytes that overlapped with astrocyte responses to clozapine and neuronal contact. These findings identify shared cholesterol-related transcriptional responses to pharmacological and genetic perturbations and link common genetic variation to distinct features of cholesterol-pathway responses.
]]></description>
<dc:creator><![CDATA[ Tegtmeyer, M., Pettinari, N., Nadig, A., Nemesh, J., Xu, H. J., Ngo, V., Hogan, M., Bolshakova, S., Liyanage, D., Peirent, E., Maglieri, A., Hawes, D., Ichihara, K., McCarroll, S. A., Nehme, R. ]]></dc:creator>
<dc:date>2026-11-17</dc:date>
<dc:identifier>doi:10.64898/2026.11.16.767064</dc:identifier>
<dc:title><![CDATA[Pharmacological and genetic access to astrocytic cholesterol programs in human neural cells]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-11-17</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.biorxiv.org/content/10.64898/2026.11.16.766929v1?rss=1">
<title>
<![CDATA[
LDEN: Alternating projections for whole genome linkage disequilibrium estimation from next-generation sequencing data 
]]>
</title>
<link>
https://www.biorxiv.org/content/10.64898/2026.11.16.766929v1?rss=1
</link>
<description><![CDATA[
Viral populations often exist as quasispecies of closely-related variants with different mutations. Variants that possess combinations of mutations conferring an overall fitness advantage replicate preferentially. Understanding the true fitness effects of mutations involves disentangling the effects of individual mutations from their genetic background. This problem becomes particularly challenging due to linkage disequilibrium, the non-random association between mutations, which can cause neutral mutations to appear fit and vice versa. Viral populations are typically studied via next-generation sequencing, in which the read length is much shorter than the genome length, rendering long-range linkage disequilibrium unobservable. Estimation of linkage disequilibrium can be performed via population reconstruction, which reconstructs complete sequences before calculating linkage disequilibrium. However, this approach is computationally slow, memory-intensive, and prone to errors, particularly in regions of low coverage. In this work, we present a novel, population reconstruction-independent method for linkage disequilibrium estimation directly from next-generation sequencing data. Our approach uses the observed intra-read linkage disequilibrium values to estimate the unobservable inter-read ones by enforcing mathematical constraints on the linkage disequilibrium matrix. Specifically, because linkage disequilibrium quantifies the covariance between mutant allele frequencies, the linkage disequilibrium matrix must be positive semidefinite. We have formulated linkage disequilibrium estimation as a matrix completion problem and solve it via alternating projections on the constraints of positive semidefiniteness and observed linkage disequilibrium values. This allows the propagation of information from observed intra-read associations to the unobservable inter-read ones without reconstructing the individual variants. We demonstrate that our method yields higher accuracy while being two orders of magnitude faster compared to population reconstruction-based estimation. We demonstrate the performance of the method on both simulated as well as real data showing that it can estimate linkage disequilibrium from a variety of populations.
]]></description>
<dc:creator><![CDATA[ Abdullah, S. M. U., Sun, Y. ]]></dc:creator>
<dc:date>2026-11-17</dc:date>
<dc:identifier>doi:10.64898/2026.11.16.766929</dc:identifier>
<dc:title><![CDATA[LDEN: Alternating projections for whole genome linkage disequilibrium estimation from next-generation sequencing data]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-11-17</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.biorxiv.org/content/10.64898/2026.11.15.766879v1?rss=1">
<title>
<![CDATA[
FoldMapper: Protein Inverse Folding Model with Structure-Derived Evolutionary Profiles and a Multiscale Graph Encoder 
]]>
</title>
<link>
https://www.biorxiv.org/content/10.64898/2026.11.15.766879v1?rss=1
</link>
<description><![CDATA[
Protein inverse folding designs amino-acid sequences that fold into a target backbone structure. Existing deep-learning methods exploit backbone geometry but not evolutionary statistics. Those statistics come from a multiple sequence alignment, which must be built from a query sequence. That query is the sequence to be designed, so the dependency is circular. We present FoldMapper, an inverse folding model that breaks this circularity. It retrieves structural homologues by shape alone, then aggregates their amino-acid identities into a per-residue structural position-specific frequency (SPSF) profile. A Multiscale Graph Encoder passes a sparse profile-conditioned encoding into a dense structure-conditioned message-passing network. FoldMapper reaches 60.0% best-of-100 sequence recovery on TED domains, 64.9% on PDB, and 51.3%/53.1% on PPIBindBench non-peptide and peptide binders. Across both benchmarks, it lies on the recovery-diversity Pareto front. Structure self-consistency surpasses all baselines on RFdiffusion de novo monomer and binder backbones, and matches the strongest baselines on natural proteins. Ablations and profile-quality analyses show that structure itself encodes recoverable evolutionary information, accessible without a sequence homology search.
]]></description>
<dc:creator><![CDATA[ Kim, H., Lee, J. ]]></dc:creator>
<dc:date>2026-11-17</dc:date>
<dc:identifier>doi:10.64898/2026.11.15.766879</dc:identifier>
<dc:title><![CDATA[FoldMapper: Protein Inverse Folding Model with Structure-Derived Evolutionary Profiles and a Multiscale Graph Encoder]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-11-17</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.biorxiv.org/content/10.64898/2026.11.15.766871v1?rss=1">
<title>
<![CDATA[
DiGi: An Integer Programming Formulation for Diploid Genome Inference Using a Pangenome Reference 
]]>
</title>
<link>
https://www.biorxiv.org/content/10.64898/2026.11.15.766871v1?rss=1
</link>
<description><![CDATA[
Compared with genotyping against a single linear reference genome, pangenome-based genotyping enables more comprehensive detection of genetic variation, including structural variants. Existing genotyping methods employ a range of combinatorial, probabilistic, and statistical techniques. One class of methods formulates genotyping as a combinatorial path-finding problem in a pangenome graph, allowing bounded recombinations between reference haplotypes. By restricting solutions to mosaics of reference haplotypes, this formulation implicitly exploits linkage disequilibrium. However, extending this formulation to diploid genomes requires jointly identifying two mosaic paths, leading to an exponential increase in the search space. To address this challenge, we first represent the pangenome as a haplotype trellis graph, which maintains reference haplotypes as separate sequences and permits switching between them only at a predefined set of positions. Second, we formulate a combinatorial optimization problem that uses sequencing reads from a target genome to jointly infer a pair of haplotype paths in the graph. We then develop a probabilistic model that automatically sets the optimization parameters based on the read length and coverage of the input data, and an integer programming formulation to solve the resulting problem exactly. Our implementation, DiGi, successfully reconstructs both paternal and maternal copies of 90% of key HLA genes in target genomes absent from the pangenome reference, achieving sequence identity above 99.9%. On the HG002 Genome in a Bottle benchmark, DiGi achieves favorable F1 scores for genotyping SNVs, indels, and structural variants in the highly polymorphic major histocompatibility complex (MHC) region. DiGi remains accurate across a wide range of sequencing coverages, which makes it well suited to population-scale studies with variable coverage across samples.
]]></description>
<dc:creator><![CDATA[ Mishra, A., Dilthey, A. T., Jain, C. ]]></dc:creator>
<dc:date>2026-11-17</dc:date>
<dc:identifier>doi:10.64898/2026.11.15.766871</dc:identifier>
<dc:title><![CDATA[DiGi: An Integer Programming Formulation for Diploid Genome Inference Using a Pangenome Reference]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-11-17</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.biorxiv.org/content/10.64898/2026.11.16.765117v1?rss=1">
<title>
<![CDATA[
Air and environmental sampling expand metagenomic viral surveillance in Cambodian pig slaughterhouses 
]]>
</title>
<link>
https://www.biorxiv.org/content/10.64898/2026.11.16.765117v1?rss=1
</link>
<description><![CDATA[
Surveillance of viruses in swine depends largely on the sampling of individual animals chosen at random, often limiting detection breadth. Environmental sampling has emerged as an alternative strategy, enabling faster, safer and more cost-effective pathogen monitoring at the human-animal interfaces. Across nine visits to two Cambodian slaughterhouses, we applied metagenomic sequencing to air samples (n = 25), faeces (n = 156), wastewater (n = 15), carcass wash water (n = 18), holding-pen swabs (n = 124), slaughter-box swabs (n = 73) and ropes (n = 16), comparing virus composition to pig snout swabs (n = 193). Combined environmental sampling recovered 96.6% of the viral taxa detected in snout swabs, exceeding 90.9% at every visit. Greater viral diversity was consistently captured in the environment, including swine-associated taxa absent from snout swabs and viral RNA associated with avian and human hosts. Air provided the widest coverage of any single environmental sample type and contributed the largest number of independent virus detections that were not recovered from any other environmental sample. Slaughter-box swabs recovered the fewest taxa, showing that visible contamination with swine material did not correlate with greater viral recovery. Overall, this study identifies air as a pivotal core component of any surveillance program. However, pairing air with additional environmental sample types provides the broadest virus coverage and represents the optimal surveillance strategy in swine slaughterhouses.
]]></description>
<dc:creator><![CDATA[ Cronin, P., Heang, V., Siegers, J. Y., Tok, S., Sin, S., Sievers, B., Omondi, V., Chhel, K., Nouhin, J., Chim, V., Seng, B., Hak, M., San, S., Tum, S., Claes, F. F., Firth, C., Su, Y. C. F., Smith, G. J. D., Karlsson, E. A. ]]></dc:creator>
<dc:date>2026-11-17</dc:date>
<dc:identifier>doi:10.64898/2026.11.16.765117</dc:identifier>
<dc:title><![CDATA[Air and environmental sampling expand metagenomic viral surveillance in Cambodian pig slaughterhouses]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-11-17</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.biorxiv.org/content/10.64898/2026.11.12.766082v1?rss=1">
<title>
<![CDATA[
Segment Anything for Microscopy 2 
]]>
</title>
<link>
https://www.biorxiv.org/content/10.64898/2026.11.12.766082v1?rss=1
</link>
<description><![CDATA[
Foundation models have advanced microscopy image segmentation, but existing models are trained on two-dimensional data, struggle with complex structures in volumetric data, and address only a narrow range of analysis tasks. Here we present Segment Anything for Microscopy 2 (SAM2), a foundation model that adapts SAM2 to joint 2D and 3D segmentation in light and electron microscopy. Trained on annotations of more than 23 million cells and nuclei and 1.6 million cellular structures, SAM2 achieves state-of-the-art automatic and interactive segmentation and outperforms generalist and specialist methods on volumetric data. Dedicated models further enable accurate mitochondrion and nucleus segmentation in electron microscopy. Beyond segmentation, SAM2 supports pixel and object classification from few annotations as well as cell tracking in 2D and 3D time-lapse data. All functionality is available in the user-friendly SAM napari plugin. We demonstrated the capabilities of SAM2 on challenging use cases spanning developmental biology, organoid research, cardiac physiology, and histopathology.
]]></description>
<dc:creator><![CDATA[ Archit, A., Teuber, C., Griebel, T., Marschhaeuser, L., Lohmann, B., Aakhte, M., Vornberger, N., von Haaren, S., Handberg-Thorsager, M., Bonne, I., Gruen, D., Beghin, A., Huisken, J., Pape, C. ]]></dc:creator>
<dc:date>2026-11-17</dc:date>
<dc:identifier>doi:10.64898/2026.11.12.766082</dc:identifier>
<dc:title><![CDATA[Segment Anything for Microscopy 2]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-11-17</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.biorxiv.org/content/10.64898/2026.11.16.766906v1?rss=1">
<title>
<![CDATA[
Pharmacophore-Inspired Virtual Receptor: Generating Realistic Peptide Binding Data for Machine Learning 
]]>
</title>
<link>
https://www.biorxiv.org/content/10.64898/2026.11.16.766906v1?rss=1
</link>
<description><![CDATA[
VReceptor is a virtual receptor simulation framework that generates realistic, sequence-dependent binding data for peptide-based therapeutics. It combines pharmacophore-inspired weighting schemes with amino acid similarity metrics to evaluate peptide design strategies in a controlled environment. Validation using the Prolactin-Releasing Peptide (PrRP) dataset confirms VReceptor's ability to approximate binding behaviours and optimize experimental planning. This framework empowers researchers in computational peptide design and active learning workflows while highlighting areas for further refinement.
]]></description>
<dc:creator><![CDATA[ Conde-Frieboes, K., Stahlhut, C. ]]></dc:creator>
<dc:date>2026-11-17</dc:date>
<dc:identifier>doi:10.64898/2026.11.16.766906</dc:identifier>
<dc:title><![CDATA[Pharmacophore-Inspired Virtual Receptor: Generating Realistic Peptide Binding Data for Machine Learning]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-11-17</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.biorxiv.org/content/10.64898/2026.11.16.766980v1?rss=1">
<title>
<![CDATA[
Sequence-based models predict TF binding with negligible contributions from motif cooperativity 
]]>
</title>
<link>
https://www.biorxiv.org/content/10.64898/2026.11.16.766980v1?rss=1
</link>
<description><![CDATA[
How transcription factors (TFs) selectively recognize their genomic targets among numerous sites containing similar DNA motifs remains an open question. Cooperative binding at neighboring motif sites is widely considered a key mechanism of TF specificity, yet its genome-wide contribution remains unclear. Machine learning models can now predict TF binding directly from DNA sequence, providing opportunities to investigate its underlying determinants. Here, we leveraged BPNet models trained on ~2,000 ENCODE TF binding profiles to systematically assess motif cooperativity. Although detected at individual loci, cooperativity made a negligible contribution to genome-wide binding predictions. Nevertheless, the models captured differences in binding preferences between TFs with similar motif preferences, even within the same cellular environment. These findings highlight the need to critically assess prevailing assumptions and explore alternative mechanisms underlying selective TF binding.
]]></description>
<dc:creator><![CDATA[ Mindel, V., Barkai, N. ]]></dc:creator>
<dc:date>2026-11-17</dc:date>
<dc:identifier>doi:10.64898/2026.11.16.766980</dc:identifier>
<dc:title><![CDATA[Sequence-based models predict TF binding with negligible contributions from motif cooperativity]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-11-17</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.biorxiv.org/content/10.64898/2026.11.15.766341v1?rss=1">
<title>
<![CDATA[
Brain disorder mechanisms and therapeutic targets identified from developmental, cell-specific gene regulation 
]]>
</title>
<link>
https://www.biorxiv.org/content/10.64898/2026.11.15.766341v1?rss=1
</link>
<description><![CDATA[
Genetic variation influences brain physiology and disease across cell types and development. We integrated whole-genome sequencing, bulk RNA sequencing, and single-nucleus multiome profiling from 231 human dorsolateral prefrontal cortex donors spanning six postconceptional weeks to 92 years. Across 24 brain-related traits, neurodevelopmental and psychiatric genetic risk was enriched in neuronal transcriptomic and chromatin profiles, whereas neurodegenerative risk was enriched in microglia. Thousands of expression, chromatin accessibility, and splicing quantitative trait loci revealed developmental and cell-type-specific regulatory effects. Colocalization linked multiple sclerosis risk to AHI1 expression in prenatal neurons and problematic alcohol use to GPX1 expression in postnatal glia. Leveraging dynamic cis-regulatory elements, we identified therapeutic candidates for haploinsufficient neurodevelopmental disorders, including a SOX5 enhancer whose CRISPR activation increased transcript and protein abundance. Together, these findings establish a publicly accessible genomic resource for resolving the developmental and cellular contexts of genetic risk and identifying therapeutic targets in the human brain.
]]></description>
<dc:creator><![CDATA[ Rohani, N., Kovner, R., Liu, Y., Garcia Guerra, A., Markati, T., Kim, S.-W., Kim, Y., Xu, Q., Wigdor, E. M., Weiss, J., Lalli, J. L., Dong, S., Nadkarni, A., Wang, X., Klei, L., Pochareddy, S., Speckhard-Pasque, D., Dema, C., Canosa, S., Cho, H., Deveau-French, A., Gordon, G., Griffiths, M., Jaisingh, K., Kachko, J., Kathail, P., Li, M., Liang, D., Ljungdahl, A., Ma, S., Makkar, R., Page, N. F., Sliby, A.-N., Zhang, M., Zhao, X., Adle-Biassette, H., Ye, C. J., Brand, H., Talkowski, M. E., De Jager, P. L., Werling, D. M., Girgenti, M. J., Rinaldi, C., Roeder, K., Devlin, B., Sestan, N., Sanders ]]></dc:creator>
<dc:date>2026-11-17</dc:date>
<dc:identifier>doi:10.64898/2026.11.15.766341</dc:identifier>
<dc:title><![CDATA[Brain disorder mechanisms and therapeutic targets identified from developmental, cell-specific gene regulation]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-11-17</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.biorxiv.org/content/10.64898/2026.11.15.766634v1?rss=1">
<title>
<![CDATA[
Casanovo-TMT: deep learning-based de novo sequencing of TMTpro-labeled peptides and phosphopeptides 
]]>
</title>
<link>
https://www.biorxiv.org/content/10.64898/2026.11.15.766634v1?rss=1
</link>
<description><![CDATA[
De novo peptide sequencing reads peptides directly from tandem mass spectra, but none of the released deep learning models can sequence peptides labeled with isobaric tags such as TMTpro, which are widely used for multiplexed quantitative proteomics. We extended the residue vocabulary of Casanovo with TMTpro tags and phosphorylation, fine-tuned it on 21 million spectra from our laboratory, most of them TMTpro-labeled, and re-ranked the candidates in the beam by their agreement with the measured precursor mass. The resulting model, Casanovo-TMT, predicted the exact peptidoform for 84.7% of the TMTpro-labeled spectra in our test set and for 87.4 and 79.6% of the spectra in two public global-proteome datasets from other laboratories, whereas the extended vocabulary without fine-tuning gave 0.3%. Discarding the lowest-scoring predictions raised precision to 95% while retaining 81.7% of the test spectra. Casanovo-TMT also predicted the exact peptidoform for 69.2% of the spectra in a public phosphopeptide-enriched dataset and for 66 to 72% of the phosphopeptide spectra in three phosphoproteomic studies from our laboratory that were not used for training. In these studies, it identified numbers of phosphopeptides comparable to or larger than those of database search engines, and proportionally more where database search identified fewer. For the phosphopeptides identified only by Casanovo-TMT, entrapment estimated that more than 90% were correct, and an independent search engine assigned the same sequence to 95 to 98% of the spectra that it identified with confidence. Casanovo-TMT can therefore extend database search in TMTpro-based quantitative proteomics, particularly in studies in which database search identifies few phosphopeptides.
]]></description>
<dc:creator><![CDATA[ Kim, H. B., Kim, K.-e. ]]></dc:creator>
<dc:date>2026-11-17</dc:date>
<dc:identifier>doi:10.64898/2026.11.15.766634</dc:identifier>
<dc:title><![CDATA[Casanovo-TMT: deep learning-based de novo sequencing of TMTpro-labeled peptides and phosphopeptides]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-11-17</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.biorxiv.org/content/10.64898/2026.11.15.766670v1?rss=1">
<title>
<![CDATA[
SRAscout: Semantic discovery of public sequencing data through harmonized SRA and BioProject metadata 
]]>
</title>
<link>
https://www.biorxiv.org/content/10.64898/2026.11.15.766670v1?rss=1
</link>
<description><![CDATA[
The rapid growth of public sequencing data has created great opportunities for data-driven discovery in the life sciences, but it has also made it harder to find relevant datasets. The NCBI Sequence Read Archive (SRA) hosts more than 45 million high-throughput sequencing runs, and the BioProject database, shared by NCBI, the European Nucleotide Archive (ENA) and the DNA Data Bank of Japan, describes the projects behind them. However, their metadata are often incomplete, inconsistently annotated and difficult to search using keywords alone. We present SRAscout, a web-based platform that enables semantic dataset retrieval by integrating SRA run metadata with the corresponding BioProject records. SRAscout collects and indexes metadata for about 714,000 BioProjects, and harmonizes sample attributes such as cell line, tissue, age, sex and treatment into a compact and consistent schema. For semantic embedding, SRAscout employs a biomedical sentence embedding model based on BioBERT, which generates dense vector representations from the title, name, organism and description of each project. Users can search in three modes, with the DOI or PubMed ID of an article, with free text, or with BioProject and SRA study accessions, and SRAscout finds the most related projects in each case. Free-text queries are processed through a hybrid of semantic and full-text search, which finds conceptually relevant studies even when different terms are used to describe the same biology, while exact terms such as gene names are still matched. Structured filters allow refinement by organism, assay type (for example RNA-seq and miRNA-seq), harmonized sample attributes such as tissue, cell type and disease, tag words, and many additional attributes. For each search, users can download a harmonized metadata table and ready-to-use scripts that fetch the sequencing files from ENA. SRAscout also offers a public API for programmatic access. By combining harmonized metadata with context-aware search in a single interface, SRAscout facilitates dataset discovery, meta-analysis and data reuse. The application is freely available at www.srascout.com.
]]></description>
<dc:creator><![CDATA[ Grigoriadis, D., Perdikopanis, N., Chan, C. S., Pavlopoulos, G., Georgakopoulos-Soares, I. ]]></dc:creator>
<dc:date>2026-11-17</dc:date>
<dc:identifier>doi:10.64898/2026.11.15.766670</dc:identifier>
<dc:title><![CDATA[SRAscout: Semantic discovery of public sequencing data through harmonized SRA and BioProject metadata]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-11-17</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.biorxiv.org/content/10.64898/2026.11.15.766769v1?rss=1">
<title>
<![CDATA[
Savant: A Fast, Structure-Free Binding Affinity Predictor For Protein-Ligand Drug Screening 
]]>
</title>
<link>
https://www.biorxiv.org/content/10.64898/2026.11.15.766769v1?rss=1
</link>
<description><![CDATA[
Protein-ligand binding affinity determines which of many candidate molecules is worth synthesizing and assaying, making it the central measurement in early drug discovery. Binding affinity is commonly expressed as the dissociation constant, an equilibrium measure that indicates how easily a complex separates into its components. AI-based generative chemistry and make-on-demand chemical catalogs now produce molecules faster than rigorous method can evaluate them. Leading computational methods co-fold the complex before scoring the binding affinity between the protein and the ligand, which provides high accuracy but requires a graphics processing unit (GPU) and substantial time for every pair evaluated.Here we present Savant, a machine learning model that estimates the dissociation constant using only the protein's amino acid sequence and the ligand's structure written as a line of text (SMILES). Savant needs no 3-dimensional folded structure, no docking, and no GPU. To test Savant fairly, we built a benchmark designed to prevent any training data to leak into the testing set, drawing only on measurements published after the training data was assembled and on molecules chemically unlike anything the model had seen. On an independent benchmark, Savant ranks ahead of every other 3-dimensional structure-free method.Savant is designed to rank compounds against a single protein, and performs as well as other methods that require a GPU, while running only on a central processing unit (CPU). Thus, Savant can screen libraries of 100,000 compounds in minutes with commodity hardware.
]]></description>
<dc:creator><![CDATA[ Guirales-Medrano, S., Ford, C. T., Janies, D. ]]></dc:creator>
<dc:date>2026-11-17</dc:date>
<dc:identifier>doi:10.64898/2026.11.15.766769</dc:identifier>
<dc:title><![CDATA[Savant: A Fast, Structure-Free Binding Affinity Predictor For Protein-Ligand Drug Screening]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-11-17</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.biorxiv.org/content/10.64898/2026.11.13.766598v1?rss=1">
<title>
<![CDATA[
A full-length isoform atlas of the non-failing and failing human heart 
]]>
</title>
<link>
https://www.biorxiv.org/content/10.64898/2026.11.13.766598v1?rss=1
</link>
<description><![CDATA[
Dilated cardiomyopathy (DCM) and ischemic heart disease (IHD) are leading causes of heart failure, yet isoform-level changes in the failing heart remain poorly defined because reference annotations are derived largely from healthy tissues and short-read sequencing cannot reliably reconstruct full-length transcripts. We sequenced six human left ventricles (non-failing, DCM, and IHD; n = 2 each) with PacBio HiFi long reads and curated 48,232 isoforms across 11,760 genes, including 15,535 novel NIC and NNC isoforms. Independent evidence supported most novel structures: 81.7% of isoforms with novel splice junctions had short-read support for all novel junctions, and a cardiac CAGE atlas supported the 5' ends of 93% of NIC and 86% of NNC isoforms. Novel isoform diversification was concentrated in sarcomere genes and persisted after accounting for gene complexity, expression, sequencing depth, and transcript length. We then augmented GENCODE v43 with 18,637 non-FSM long-read isoforms and re-quantified two independent short-read cohorts (MAGNet and GSE116250). For most genes carrying a transcript that changed more than 2-fold in DCM, the gene itself changed less than 2-fold, so these changes are not apparent at the gene level. Of 626 transcripts differentially expressed in both cohorts, 98% changed in the same direction, including all 100 long-read isoforms among them. The resource is available through CardioIsoMap, an interactive isoform-centric portal (https://cardioisomap.streamlit.app/). This study provides a comprehensive isoform-resolved reference of the human heart in health and disease.
]]></description>
<dc:creator><![CDATA[ Ye, B., Noureen, M., He, F., Lingamgunta, L., Zheng, S., Li, F., Wang, X. ]]></dc:creator>
<dc:date>2026-11-17</dc:date>
<dc:identifier>doi:10.64898/2026.11.13.766598</dc:identifier>
<dc:title><![CDATA[A full-length isoform atlas of the non-failing and failing human heart]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-11-17</prism:publicationDate>
<prism:section></prism:section>
</item>
</rdf:RDF>
